MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹5.92 Cr | ₹4.56 Cr | ₹3.25 Cr | ₹1.86 Cr | ₹2.11 Cr |
What is the latest Long Term Provisions ratio of MARKSANS PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹5.92 Cr |
| Mar2024 | ₹4.56 Cr |
| Mar2023 | ₹3.25 Cr |
| Mar2022 | ₹1.86 Cr |
| Mar2021 | ₹2.11 Cr |
How is Long Term Provisions of MARKSANS PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.92 Cr | 29.85 | |
| Mar2024 | ₹4.56 Cr | 40.19 | |
| Mar2023 | ₹3.25 Cr | 75.22 | |
| Mar2022 | ₹1.86 Cr | -12.08 | |
| Mar2021 | ₹2.11 Cr | - | |
Compare Long Term Provisions of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹12,093.6 Cr | -1.5% | 2.1% | 4.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹116,447.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -1.5% |
2.1% |
4.9% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses